University of Bern spinout Arctos Medical has been acquired by existing shareholder Novartis.

Arctos Medical, a Switzerland-based developer of gene therapies to restore sight that was spun out of University of Bern, was acquired by pharmaceutical firm Novartis for an undisclosed amount today. Founded in 2012, Arctos Medical is working on optogenetics-based adeno-associated virus gene therapies to treat diseases that involve photoreceptor loss – causing blindness – such…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.